A detailed history of Chilton Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Chilton Capital Management LLC holds 39 shares of DXCM stock, worth $2,959. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39
Previous 22 77.27%
Holding current value
$2,959
Previous $2,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$64.0 - $116.06 $1,088 - $1,973
17 Added 77.27%
39 $2,000
Q2 2024

Aug 01, 2024

BUY
$110.31 - $140.45 $2,426 - $3,089
22 New
22 $2,000
Q1 2023

May 15, 2023

BUY
$104.0 - $122.92 $156,832 - $185,363
1,508 New
1,508 $175,000
Q2 2022

Aug 16, 2022

BUY
$67.99 - $132.89 $8,974 - $17,541
132 New
132 $10,000
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $1,975 - $2,734
-21 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $2,727 - $3,419
21 New
21 $11,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Chilton Capital Management LLC Portfolio

Follow Chilton Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chilton Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chilton Capital Management LLC with notifications on news.